Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Unique Cause of Persistent Diarrhea

Tomoya Iida1, Kentaro Yamashita1, Hiroshi Nakase1

  • 1Department of Gastroenterology and Hepatology, Sapporo Medical University, School of Medicine, Sapporo, Japan.

Gastroenterology
|April 7, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Personalized and stratified therapy in ulcerative colitis:what is feasible at present and how far have we advanced?]

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026
Same author

Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study.

Intestinal research·2026
Same author

Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials.

Intestinal research·2026
Same author

A Rare Case of Ileoileal Fistula Concomitant with Adenocarcinoma in a Patient with Crohn's Disease.

Inflammatory intestinal diseases·2026
Same author

Inflammasomes in Intestinal Inflammation: Guardians of Mucosal Homeostasis, Amplifiers of Disease, and Targets for Intervention.

Internal medicine (Tokyo, Japan)·2026
Same author

Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Crohn's & colitis 360·2026